-
1
-
-
0029396980
-
Botulinum toxin type B in the treatment of cervical dystonia: A pilot study
-
Tsui, J. K., Hayward, M., Mak, E. K., et al. Botulinum toxin type B in the treatment of cervical dystonia: A pilot study. Neurology 45: 2109, 1995.
-
(1995)
Neurology
, vol.45
, pp. 2109
-
-
Tsui, J.K.1
Hayward, M.2
Mak, E.K.3
-
2
-
-
0030853667
-
Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
-
Lew, M. F., Adornato, B. T., Duane, D. D., et al. Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49: 701, 1997.
-
(1997)
Neurology
, vol.49
, pp. 701
-
-
Lew, M.F.1
Adornato, B.T.2
Duane, D.D.3
-
3
-
-
0034719053
-
The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials
-
Lew, M. F., Brashear, A., and Factor, S. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled clinical trials. Neurology 55: S29, 2000.
-
(2000)
Neurology
, vol.55
-
-
Lew, M.F.1
Brashear, A.2
Factor, S.3
-
4
-
-
0032718516
-
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
-
Brashear, A., Lew, M. F., Dykstra, D. D., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53: 1439, 1999.
-
(1999)
Neurology
, vol.53
, pp. 1439
-
-
Brashear, A.1
Lew, M.F.2
Dykstra, D.D.3
-
5
-
-
0034719038
-
The biochemistry of botulinum toxin type B
-
Setler, P. The biochemistry of botulinum toxin type B. Neurology 55: S22, 2000.
-
(2000)
Neurology
, vol.55
-
-
Setler, P.1
-
6
-
-
0035130709
-
Botulinum toxin: Basic science and clinical uses in otolaryngology
-
Blitzer, A., and Sulica, L. Botulinum toxin: Basic science and clinical uses in otolaryngology. Laryngoscope 111: 218, 2001.
-
(2001)
Laryngoscope
, vol.111
, pp. 218
-
-
Blitzer, A.1
Sulica, L.2
-
7
-
-
33748271738
-
Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
-
Brin, M. F. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 6: S146, 1997.
-
(1997)
Muscle Nerve Suppl.
, vol.6
-
-
Brin, M.F.1
-
8
-
-
0034918865
-
Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology
-
Callaway, J. E., Arezzo, J. C., and Grethlein, A. J. Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology. Semin. Cutan. Med. Surg. 20: 127, 2001.
-
(2001)
Semin. Cutan. Med. Surg.
, vol.20
, pp. 127
-
-
Callaway, J.E.1
Arezzo, J.C.2
Grethlein, A.J.3
-
9
-
-
0036560715
-
Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines
-
Ramirez, A. L., Reeck, J., and Maas, C. S. Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines. Otolaryngol. Head Neck Surg. 126: 459, 2002.
-
(2002)
Otolaryngol. Head Neck Surg.
, vol.126
, pp. 459
-
-
Ramirez, A.L.1
Reeck, J.2
Maas, C.S.3
-
10
-
-
0028016230
-
Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study
-
Keen, M., Blitzer, A., Aviv, J., et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast. Reconstr. Surg. 94: 94, 1994.
-
(1994)
Plast. Reconstr. Surg.
, vol.94
, pp. 94
-
-
Keen, M.1
Blitzer, A.2
Aviv, J.3
-
11
-
-
0030481450
-
Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique
-
Lowe, N.J., Maxwell, A., and Harper, H. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J. Am. Acad. Dermatol. 35: 569, 1996.
-
(1996)
J. Am. Acad. Dermatol.
, vol.35
, pp. 569
-
-
Lowe, N.J.1
Maxwell, A.2
Harper, H.3
-
12
-
-
0029981227
-
The use of botulinum A toxin to ameliorate facial kinetic frown lines
-
Foster, J. A., Barnhorst, D., Papay, F., et al. The use of botulinum A toxin to ameliorate facial kinetic frown lines. Ophthalmology 103: 618, 1996.
-
(1996)
Ophthalmology
, vol.103
, pp. 618
-
-
Foster, J.A.1
Barnhorst, D.2
Papay, F.3
-
13
-
-
0030963474
-
The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients
-
Blitzer, A., Binder, W. J., Aviv, J. E., et al. The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients. Arch. Otolaryngol. Head Neck Surg. 123: 389, 1997.
-
(1997)
Arch. Otolaryngol. Head Neck Surg.
, vol.123
, pp. 389
-
-
Blitzer, A.1
Binder, W.J.2
Aviv, J.E.3
-
14
-
-
33750886088
-
Radiated scale for evaluation of hyperkinetic lines
-
in press
-
Kim, E. J., et al. Radiated scale for evaluation of hyperkinetic lines. Arch. Facial Plast. Surg. (in press).
-
Arch. Facial Plast. Surg.
-
-
Kim, E.J.1
-
15
-
-
0034576744
-
Measuring injection-site pain associated with vaccine administration in adults: A randomised, double-blind, placebo-controlled clinical trial
-
Su, L., Tucker, R., Frey, S. E., et al. Measuring injection-site pain associated with vaccine administration in adults: A randomised, double-blind, placebo-controlled clinical trial. J. Epidemiol. Biostat. 5: 359, 2000.
-
(2000)
J. Epidemiol. Biostat.
, vol.5
, pp. 359
-
-
Su, L.1
Tucker, R.2
Frey, S.E.3
-
17
-
-
0025989861
-
Quantifying the spread of botulinum toxin through muscle fascia
-
Shaari, C. M., George, E., Wu, B. L., et al. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 101: 960, 1991.
-
(1991)
Laryngoscope
, vol.101
, pp. 960
-
-
Shaari, C.M.1
George, E.2
Wu, B.L.3
-
18
-
-
0027976367
-
Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections
-
Borodic, G. E., Ferrante, R., Pearce, L. B., et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov. Disord. 9: 31, 1994.
-
(1994)
Mov. Disord.
, vol.9
, pp. 31
-
-
Borodic, G.E.1
Ferrante, R.2
Pearce, L.B.3
|